Stocks · News reference
Louis DeStefano, Chief Growth Officer at Oscar Health, highlighted the strategic importance of CHOICE arrangements in employer-sponsored healthcare during the 2026 EBRI-SHRM Health Benefits Symposium.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Oscar Health is diversifying revenue streams beyond ACA insurance through Lucie, an enhanced direct enrollment platform targeting a $650+ billion marketplace, and CHOICE, which capitalizes on growing ICHRA adoption. While the company has gained 116.1% year-to-date, its stock trades at a premium valuation (P/E of 14.17 vs. industry average of 9.02) with consensus estimates showing projected revenue and earnings decreases for 2026-2027.
Oscar Health will not participate in the New York State of Health Marketplace for the 2027 plan year, affecting approximately 4,800 consumers.
Oscar Health is among the insurance companies identified by U.S. senators as having complied with a CMS data request that led to the termination of coverage for hundreds of thousands of ACA marketplace enrollees.